Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004984153 | SCV005613635 | uncertain significance | Inborn genetic diseases | 2024-10-04 | criteria provided, single submitter | clinical testing | The c.8738G>A (p.G2913E) alteration is located in exon 38 (coding exon 38) of the KMT2C gene. This alteration results from a G to A substitution at nucleotide position 8738, causing the glycine (G) at amino acid position 2913 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |